Clinical trials: Microvascular Obstruction
- Condition Microvascular Obstruction
- Funder type Industry (pharma, biotech, devices)
- Has posted results yes
Microvascular Obstruction
A Study Evaluating the Safety, Tolerability, and Effect on Microvascular Obstruction of Intravenous Temanogrel in Adult Participants Undergoing Percutaneous Coronary Intervention
The purpose of this study is to determine whether intravenous temanogrel is a safe and effective treatment for microvascular obstruction (MVO) in adult participants undergoing percutaneous coronary intervention (PCI).
- Trial name
- NCT04848220
- Testing
- Temanogrel
- Where
- 12 sites in United States, Australia and 3 more
- Volunteers
- 29 people
- Sponsor
- Pfizer